Trial Profile
A prospective cohort study to assess PrEP uptake, safety and efficacy in our hospital-based clinic
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2018
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 12 Jul 2018 Results published in the AIDS
- 30 Aug 2017 New trial record
- 26 Jul 2017 Results presented at the 9th International AIDS Society Conference on HIV Science